Søgning
Søgning på udtrykket 'hepatitis c' giver 44 resultater
Dokumenter [2] Sider [1] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Dokumenter [2]
National guideline udarbejdet af en arbejdsgruppe nedsat af medlemmer fra Dansk Selskab for Infektionsmedicin og medlemmer fra Dansk Selskab for Gastroenterologi og Hepatologi.
Sider [1]
…is: Akut viral hepatitis: Carsten Shade Larsen (tovholder) og Nina Weis.
Professor Henrik Nielsen kommenterer: I disse år sker et paradigmeskift i behandlingen af kronisk hepatitis C virus infektionen. Mange direkte virkende lægemidler er i afprøvning og med lovende resultater. Snart er interferon-baseret terapi ikke absolut nødvendig, mens oral terapi af kort varighed synes indenfor rækkevidde. Samtidigt er bivirkninger ved de nye lægemidler hidtil beskrevet som milde og sjældne.
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
Proceedings of the National Academy of Sciences
17.04.2025
Proceedings of the National Academy of Sciences, Volume 122, Issue 15, April 2025. SignificanceChronic hepatitis C virus (HCV) infection causing liver cirrhosis and cancer affects about 50 million individuals, making it a major global health burden. Neutralizing antibodies target different epitopes on the HCV E1E2 glycoprotein .
Journal of the American Medical Association
16.04.2025
This study examines whether hepatitis C virus screening differs among pregnant and nonpregnant women.
Clinical Infectious Diseases
15.04.2025
Abstract . Background . Hepatitis C virus (HCV) is a leading cause of infectious disease death in the United States. Although highly effective direct-acting antiviral (DAA) regimens are well established, retreatment among people who inject drugs (PWID) has not been sufficiently studied. This study assessed DAA retreatment outcomes and associated factors.Methods .
BMC Infectious Diseases
9.04.2025
. Introduction. This study aimed to evaluate the epidemiological trends and spatial-temporal distribution of hepatitis C virus (HCV) in mainland China. . Methods. HCV monthly incidence surveillance data from 2004 to 2018 was mainly available from the Public Health Sciences Data Center of China.
BMJ Open
25.03.2025
. Objective. We identified factors associated with hepatitis C virus (HCV) testing in the previous 6 months in people who inject drugs (PWID) according to gender. . Design. COSINUS (Cohorte pour l’évaluation des facteurs Structurels et Individuels de l’USage de drogues) is a multisite longitudinal cohort study conducted between June 2016 and May 2019. . Setting. Harm reduction facilities in two French cities (Marseille and Bordeaux). . Participants.
BMC Infectious Diseases
22.03.2025
. Objective. The purpose of this study was to analyze the epidemiological characteristics and spatial-temporal distribution characteristics of hepatitis C in Fujian Province, China, from 2015 to 2022, and to provide reference for the risk identification, early warning and prevention and control measures of hepatitis C in Fujian Province. . Methods.
Science Advances
20.03.2025
Science Advances, Volume 11, Issue 12, March 2025.
AIDS
1.03.2025
Objective: . People with HIV-HCV co-infection need antiretroviral treatment (ART) to suppress HIV and direct-acting antivirals (DAAs) to cure HCV. ART is typically prioritized, but delays in DAA initiation may increase the risk of liver-related events and HCV transmission to others. Design: . Target trial emulation with observational data collected in routine clinical practice from a collaboration of cohorts from Europe and North America. Methods: .
Journal of Acquired Immune Deficiency Syndromes
28.02.2025
Background: . Successful treatment of hepatitis C virus (HCV) can lead to liver fibrosis regression. It is not known who will experience fibrosis regression or how quickly it will occur. Methods: . We modelled transient elastography (TE) measurements from 1470 HIV-HCV coinfected participants followed in cohorts contributing data to InCHEHC, an international collaboration.
PLoS One Infectious Diseases
21.02.2025
…e P. Maro, Elichilia R. Shao . Background The coexistence of viral hepatitis with diabetes mellitus (DM) significantly escalates the risk of severe outcomes. This study aimed to determine the seroprevalence and associated factors of hepatitis B (HBV) and hepatitis C (HCV) viral infections among DM patients in northern Tanzania.
Journal of Medical Virology
19.02.2025
Journal of Medical Virology, Volume 97, Issue 2, February 2025.
Clinical Infectious Diseases
13.02.2025
To the Editor—We read with real interest the study by Biondi et al [1] analyzing the disparities of care of hepatitis C virus infection in reproductive-aged women with opioid use disorder. The authors conclude by calling for interventions to improve overall rates and equity in hepatitis C virus screening and treatment for women of reproductive age and highlight the negative impact of racial and ethnic disparities.
Clinical Infectious Diseases
31.01.2025
Abstract . Sofosbuvir/velpatasvir/voxilaprevir is recommended for hepatitis C virus (HCV) retreatment in those who fail initial treatment but is unavailable in resource-limited settings. We describe a government sofosbuvir/velpatasvir + ribavirin (SOF/VEL + RBV) × 24 weeks retreatment program in Rwanda (November 2021–October 2022). Of 231 participants, 174 were cured (75.3% intention-to-treat analysis). SOF/VEL + RBV may be considered for HCV retreatment in resource-limited settings.
PLoS One Infectious Diseases
17.01.2025
by Ajit Patil, Pallavi Vidhate, Sandip Patil, Amrita Rao, Swarali Kurle, Samiran Panda . Viral hepatitis is a major public health challenge. Hepatitis C Virus (HCV) infection causes the progressive liver damage.
Clinical Infectious Diseases
15.01.2025
Clinical Infectious Diseases
11.01.2025
Abstract . Background . Chronic hepatitis C virus (HCV) infection affects >1% of the U.S. population, higher among U.S. Veterans. Direct-acting antiviral (DAA) medications are effective for viral cure, termed sustained virologic response (SVR), but repeat viremia after SVR is recognized. Prior work has been limited by use of electronic medical record data. We aim to better understand repeat viremia in the DAA era through detailed chart review.Methods .
PLoS One Infectious Diseases
1.01.2025
by Sayamon Hongjaisee, Woottichai Khamduang, Nang Kham-Kjing, Nicole Ngo-Giang-Huong, Arunrat Tangmunkongvorakul . During the COVID-19 pandemic, sex workers (SW) were one of the vulnerable groups affected by lockdown measures. COVID-19 had also disrupted HIV/Sexually transmitted infection (STI) testing and treatment services for sex workers due to numerous restrictions in specialist medical care.
New England Journal of Medicine
29.12.2024
New England Journal of Medicine, Ahead of Print.
BMJ Open
25.12.2024
. Objectives. This study aimed to explore the spatial and temporal distribution of hepatitis C and its influencing factors in Chongqing, providing a scientific basis for the relevant departments to formulate targeted preventive measures for the high prevalence of hepatitis C in the region and population. . Design.
Journal of Medical Virology
19.12.2024
Journal of Medical Virology, Volume 96, Issue 12, December 2024.
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
Morbidity and Mortality Weekly Report (MMWR)
28.03.2025
This report describes the annual rate of newly reported chronic hepatitis C among adults in Alaska.
ProMED
28.03.2025
. . . HEPATITIS C - USA: (FLORIDA) NOSOCOMIAL. ***************************************. A ProMED-mail post. www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases. www.isid.org . Date: Sat 22 Mar 2025 . Source: Florida Today [edited] . www.floridatoday.com/story/news/local/2025/03/22/florida-surgeon-general-ladapo-emergency-restriction-melbourne-doctor-hepatitis-c-cluster/82544616007/ . . .
ProMED
27.02.2025
. . . HEPATITIS C - INDIA: (UTTARAKHAND). **********************************. A ProMED-mail post. www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases. www.isid.org . Date: Sat 22 Feb 2025 10:13 IST . Source: The Times of India (TOI), Times News Network (TNN) [edited] .
ProMED
20.01.2025
. . . HEPATITIS C - PAKISTAN: INCREASED NUMBERS. *****************************************. A ProMED-mail post. www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases. www.isid.org . Date: Sun 12 Jan 2025 . Source: The Dawn [edited] . www.dawn.com/news/1884593/pakistan-tops-world-in-hepatitis-c-cases-pms-aide . . . Pakistan tops world in hepatitis C cases: PM's aide . --------------------------------------------- .
Eurosurveillance latest updates
15.11.2024
. Background. Hepatitis C virus (HCV) infection is targeted for elimination as a public health threat by 2030. The World Health Organization goal for treatment uptake is ≥ 80% among cases diagnosed with an active HCV infection (RNA- or core antigen-positive), maintained for 2 years. . . Aim. To calculate treatment uptake, time from diagnosis to treatment start and complete treatment dispensation among notified cases of HCV infection in Norway. . . Method.
Medscape Infectious Diseases
7.11.2024
The rate of HCV reinfection was high in the immediate posttreatment period among individuals who injected drugs but decreased significantly over time. . Medscape Medical News
Medscape Infectious Diseases
28.09.2024
The study highlighted that 57.7% of neonates in the case group had a diagnosis of neonatal abstinence syndrome compared to 10.0% in the control group. . Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
2.08.2024
This report describes progress toward eliminating hepatitis B and C in the country of Georgia.
Eurosurveillance latest updates
26.07.2024
. Introduction. Obtaining epidemiological data on chronic hepatitis C virus (HCV) infection is essential to monitor progress towards the hepatitis C elimination targets. . . Aim. We aimed to estimate the prevalence of chronic HCV and the seroprevalence of HCV in the adult general population in Estonia. . . Methods.
Eurosurveillance latest updates
26.07.2024
. Introduction. A national study from 2006 to 2008 showed a high antibody prevalence of 3.2% against hepatitis C virus (HCV) in Romania, but more recent epidemiological data on hepatitis C prevalence are lacking. . . Aim. We aimed to estimate the current prevalence of HCV antibodies (anti-HCV) and chronic HCV infection in the general adult population in Romania, as a crucial element in monitoring progress towards eliminating hepatitis C. . . Methods.
Eurosurveillance latest updates
26.07.2024
.
Eurosurveillance latest updates
20.07.2024
. Background. People who use drugs (PWUD) are a key target population to reduce the burden of hepatitis C virus (HCV) infection. . . Aim. To assess risk factors and temporal trends of active HCV infection in PWUD in Madrid, Spain. . . Methods. We conducted a retrospective study between 2017 and 2023, including 2,264 PWUD visiting a mobile screening unit. Data about epidemiology, substance use and sexual risk behaviour were obtained through a 92-item questionnaire.
Eurosurveillance latest updates
20.07.2024
. Background. Active follow-up of chronic hepatitis C notifications to promote linkage to care is a promising strategy to support elimination. . . Aim. This pilot study in Victoria, Australia, explored if the Department of Health could follow-up on hepatitis C cases through their diagnosing clinicians, to assess and support linkage to care and complete data missing from the notification. . . Methods.
Morbidity and Mortality Weekly Report (MMWR)
31.05.2024
This report describes hepatitis C viral clearance proportions among people with hepatitis C by state.
ProMED
11.04.2025
…urity Agency (UKHSA) Virus. Reference Laboratory, London. Molecular testing with PCR was done for. adeno-associated virus (AAV)2, HAdV, HAdV species F40/41 (in NVRL),. cytomegalovirus (CMV), Epstein-Barr virus (EBV), enterovirus,. hepatitis A virus (HAV), hepatitis C virus (HCV), hepatitis E virus. (HEV), HHV-6, HHV-7, herpes simplex virus (HSV) type 1, parechovirus. and parvovirus B19. Serological testing was done for CMV, EBV viral. capsid antigen (VCA), nuclear antigen 1 of EBV (EBNA), HAV, hepatitis.
ProMED
10.04.2025
…a spike in hepatitis infections in Pallam village, following. over 10 days of persistent fever cases and illness among residents. . District Medical and Health Officer (DMHO) Dr Durga Rao Dora confirmed. 19 Hepatitis B Surface Antigen (HBSAG) cases and 9 Hepatitis C Virus. (HCV) infections after a large-scale screening of over 2300 residents. He said the cluster warranted special attention and assured that. medical teams were monitoring the situation and taking preventive. measures.
ProMED
4.04.2025
…us dysgalactiae_ were isolated; however, the. lesion was healing at the time of presentation. No other organisms. were isolated from blood cultures or other specimens. . There was no significant past medical history except in one patient. who had chronic hepatitis C and a recent deep vein thrombosis. . Discussion . ----------- . This report describes the first documented cluster in England of. non-toxigenic _C. diphtheriae_ infections, presenting as infective.
ProMED
4.03.2025
…nced updates to its infectious disease. dashboard, which also provides statistics on gastrointestinal diseases. such as salmonella, listeria, and _E. coli_, as well as information on. influenza, measles, chicken pox, malaria, West Nile virus, and chronic. hepatitis C. . 'The health department uses reports of disease to determine who is at. risk and how to prevent transmission,' said Brandon Doumont, the. health department epidemiologist and coordinator of the dashboard.
Medscape Infectious Diseases
31.01.2025
Having peers facilitate virtual visits may lead to many more patients with hepatitis C receiving treatment and clearing the virus, research showed. . Medscape Medical News
Medscape Infectious Diseases
2.01.2025
Biomarker staging of liver fibrosis in hepatitis C was cost effective, but so was initiating treatment without testing. . Medscape Medical News